Thorough QT/QTc trial of laninamivir in volunteers.

Trial Profile

Thorough QT/QTc trial of laninamivir in volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 27 Sep 2014

At a glance

  • Drugs Laninamivir (Primary)
  • Indications Influenza virus infections
  • Focus Adverse reactions
  • Sponsors Biota Pharmaceuticals
  • Most Recent Events

    • 27 Sep 2014 Status changed from unconfirmed to completed.
    • 27 Sep 2014 New trial record
    • 19 Nov 2013 Data from this trial will support a New Drug Application for laninamivir, according to a Biota Pharmaceuticals media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top